Ironwood Pharmaceuticals (IRWD) Leases: 2010-2025
Historic Leases for Ironwood Pharmaceuticals (IRWD) over the last 7 years, with Sep 2025 value amounting to $9.8 million.
- Ironwood Pharmaceuticals' Leases fell 14.48% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 14.48%. This contributed to the annual value of $11.0 million for FY2024, which is 12.38% down from last year.
- As of Q3 2025, Ironwood Pharmaceuticals' Leases stood at $9.8 million, which was down 4.18% from $10.2 million recorded in Q2 2025.
- In the past 5 years, Ironwood Pharmaceuticals' Leases ranged from a high of $16.3 million in Q1 2021 and a low of $9.8 million during Q3 2025.
- In the last 3 years, Ironwood Pharmaceuticals' Leases had a median value of $11.8 million in 2024 and averaged $11.8 million.
- Data for Ironwood Pharmaceuticals' Leases shows a maximum YoY declined of 14.48% (in 2025) over the last 5 years.
- Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Leases stood at $15.3 million in 2021, then decreased by 8.64% to $14.0 million in 2022, then fell by 10.25% to $12.6 million in 2023, then fell by 12.38% to $11.0 million in 2024, then dropped by 14.48% to $9.8 million in 2025.
- Its Leases was $9.8 million in Q3 2025, compared to $10.2 million in Q2 2025 and $10.6 million in Q1 2025.